Sanofi - stock earnings
SNY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 2.2 billion USD | 25.3 billion USD |
| 2023Q3 | 2.7 billion USD | 13.4 billion USD |
| 2023Q2 | 1.6 billion USD | 11.6 billion USD |
| 2023Q1 | 2.2 billion USD | 11.8 billion USD |
| 2022Q4 | 3.3 billion USD | 12.3 billion USD |
| 2022Q3 | 2.0 billion USD | 12.9 billion USD |
| 2022Q2 | 1.2 billion USD | 11.2 billion USD |
| 2022Q1 | 2.2 billion USD | 11.2 billion USD |
| 2021Q4 | 1.3 billion USD | 11.8 billion USD |
| 2021Q3 | 2.7 billion USD | 12.5 billion USD |
| 2021Q2 | 1.4 billion USD | 10.7 billion USD |
| 2021Q1 | 1.8 billion USD | 10.4 billion USD |
| 2020Q4 | 1.3 billion USD | 11.9 billion USD |
| 2020Q3 | 2.3 billion USD | 11.6 billion USD |
| 2020Q2 | 8.5 billion USD | 9.5 billion USD |
| 2020Q1 | 1.9 billion USD | 10.3 billion USD |
| 2019Q4 | -320.4 million USD | 11.2 billion USD |
| 2019Q3 | 1.9 billion USD | 10.9 billion USD |
| 2019Q2 | -643.7 million USD | 10.2 billion USD |
| 2019Q1 | 1.3 billion USD | 9.8 billion USD |
| 2018Q4 | -231.1 million USD | 10.7 billion USD |
| 2018Q3 | 2.6 billion USD | 11.3 billion USD |
| 2018Q2 | 881.1 million USD | 9.8 billion USD |
| 2018Q1 | 1.2 billion USD | 10.0 billion USD |
| 2017Q4 | -21.5 million USD | 10.7 billion USD |
| 2017Q3 | 1.8 billion USD | 11.1 billion USD |
| 2017Q2 | 1.2 billion USD | 10.2 billion USD |
| 2017Q1 | 1.4 billion USD | 9.5 billion USD |
| 2016Q4 | 831.2 million USD | 9.7 billion USD |
| 2016Q3 | 1.9 billion USD | 10.4 billion USD |
| 2016Q2 | 1.3 billion USD | 9.2 billion USD |
| 2016Q1 | 1.2 billion USD | 9.0 billion USD |
| 2015Q4 | -138.9 million USD | 7.5 billion USD |
| 2015Q3 | 1.8 billion USD | 10.9 billion USD |
| 2015Q2 | 1.5 billion USD | 9.1 billion USD |
| 2015Q1 | 1.1 billion USD | 9.6 billion USD |
| 2014Q4 | 1.6 billion USD | 8.6 billion USD |
| 2014Q3 | 1.5 billion USD | 11.3 billion USD |
| 2014Q2 | 1.1 billion USD | 11.1 billion USD |
| 2014Q1 | 1.5 billion USD | 10.9 billion USD |
| 2013Q4 | 1.5 billion USD | 11.8 billion USD |
| 2013Q3 | 1.6 billion USD | 11.5 billion USD |
| 2013Q2 | 584.0 million USD | 10.5 billion USD |
| 2013Q1 | 1.3 billion USD | 10.5 billion USD |
| 2012Q4 | -110.8 million USD | 11.4 billion USD |
| 2012Q3 | 2.0 billion USD | 11.9 billion USD |
| 2012Q2 | 1.4 billion USD | 11.3 billion USD |
| 2012Q1 | 2.4 billion USD | 11.9 billion USD |
| 2011Q4 | 1.9 billion USD | 11.6 billion USD |
| 2011Q3 | 2.8 billion USD | 12.5 billion USD |
| 2011Q2 | 1.1 billion USD | 12.7 billion USD |
| 2011Q1 | 1.7 billion USD | 11.6 billion USD |
| 2010Q4 | 319.2 million USD | 10.4 billion USD |
| 2010Q3 | 1.7 billion USD | 11.3 billion USD |
| 2010Q2 | 2.1 billion USD | 10.0 billion USD |
| 2010Q1 | 2.3 billion USD | 10.5 billion USD |
| 2009Q4 | 1.7 billion USD | 11.1 billion USD |
| 2009Q3 | 2.1 billion USD | 11.4 billion USD |
| 2009Q2 | 1.5 billion USD | 10.9 billion USD |
| 2009Q1 | 2.1 billion USD | 9.9 billion USD |
| 2008Q4 | -2.1 billion USD | 10.4 billion USD |
| 2008Q3 | 2.7 billion USD | 10.1 billion USD |
| 2008Q2 | 1.8 billion USD | 11.2 billion USD |
| 2008Q1 | 2.9 billion USD | 11.4 billion USD |
| 2007Q4 | 1.9 billion USD | 11.9 billion USD |
| 2007Q3 | 1.9 billion USD | 9.9 billion USD |
| 2007Q2 | 1.8 billion USD | 9.9 billion USD |
| 2007Q1 | 1.8 billion USD | 9.4 billion USD |
| 2006Q4 | 1.1 billion USD | 9.7 billion USD |
| 2006Q3 | 1.0 billion USD | 9.3 billion USD |
| 2006Q2 | 1.1 billion USD | 9.5 billion USD |
| 2006Q1 | 1.8 billion USD | 8.9 billion USD |
| 2005Q4 | 539.5 million USD | 8.7 billion USD |
| 2005Q3 | 858.8 million USD | 9.0 billion USD |
| 2005Q2 | 656.1 million USD | 8.2 billion USD |
| 2005Q1 | 1.8 billion USD | 8.6 billion USD |
| 2004Q4 | -3.2 billion USD | 7.2 billion USD |
| 2004Q3 | -2.9 billion USD | 6.6 billion USD |
| 2004Q2 | 692.2 million USD | 2.7 billion USD |
| 2004Q1 | 699.6 million USD | 2.7 billion USD |
| 2003Q4 | 614.4 million USD | 2.2 billion USD |
| 2003Q3 | 762.7 million USD | 2.8 billion USD |
| 2003Q2 | 538.3 million USD | 2.2 billion USD |
| 2003Q1 | 512.5 million USD | 2.1 billion USD |
| 2002Q4 | 487.6 million USD | 2.0 billion USD |
| 2002Q3 | 455.3 million USD | 1.8 billion USD |
| 2002Q2 | 413.7 million USD | 1.8 billion USD |
| 2001Q4 | 1.2 billion USD | 5.1 billion USD |
| 2000Q4 | 865.6 million USD | 5.2 billion USD |
SNY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 6.0 billion USD | 47.6 billion USD |
| 2022 | 9.0 billion USD | 48.7 billion USD |
| 2021 | 7.1 billion USD | 44.6 billion USD |
| 2020 | 15.0 billion USD | 45.5 billion USD |
| 2019 | 3.1 billion USD | 42.2 billion USD |
| 2018 | 4.9 billion USD | 40.8 billion USD |
| 2017 | 4.7 billion USD | 43.3 billion USD |
| 2016 | 5.0 billion USD | 36.5 billion USD |
| 2015 | 4.7 billion USD | 38.1 billion USD |
| 2014 | 5.3 billion USD | 38.9 billion USD |
| 2013 | 5.1 billion USD | 43.2 billion USD |
| 2012 | 6.6 billion USD | 47.4 billion USD |
| 2011 | 7.4 billion USD | 45.4 billion USD |
| 2010 | 5.8 billion USD | 42.6 billion USD |
| 2009 | 7.5 billion USD | 44.1 billion USD |
| 2008 | 10.0 billion USD | 40.2 billion USD |
| 2007 | 7.7 billion USD | 42.7 billion USD |
| 2006 | 5.3 billion USD | 38.9 billion USD |
| 2005 | 2.7 billion USD | 33.7 billion USD |
| 2004 | -3.6 billion USD | 20.4 billion USD |
| 2003 | 2.6 billion USD | 10.1 billion USD |
| 2002 | 1.8 billion USD | 7.8 billion USD |
| 2001 | 1.4 billion USD | 5.7 billion USD |
| 2000 | 922.1 million USD | 5.6 billion USD |
| 1999 | 627.9 million USD | 5.4 billion USD |
SNY
Price: $49.23
52 week price:
Dividend Yield: 0.08%
5-year range yield:
Forward Dividend Yield: 4.14%
Payout Ratio: 87.44%
Payout Ratio Range:
Dividend Per Share: 2.04 USD
Earnings Per Share: 2.29 USD
P/E Ratio: 19.91
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 337528
Ebitda: 1.5 billionMarket Capitalization: 116.1 billion
Average Dividend Frequency: 2
Years Paying Dividends: 22
DGR3: 2.98%
DGR5: 0.64%
DGR10: 0.61%